Virgin Galactic Holdings (SPCE) Earnings Analysis
Virgin Galactic Holdings (SPCE) has no confirmed upcoming earnings date. Last quarter (2026-05-14) it missed with EPS -0.81 USD vs -0.79 USD est (-2.5%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -0.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SPCE next report earnings?
No confirmed upcoming earnings date is currently scheduled for SPCE. This page updates as the calendar is published.
SPCE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.81 USD | -0.79 USD | -2.5% | Miss |
| 2026-03-30 | -0.98 USD | -1.0353 USD | +5.3% | Beat |
| 2025-11-13 | -1.09 USD | -1.51 USD | +27.8% | Beat |
| 2025-05-15 | -2.38 USD | -2.23 USD | -6.7% | Miss |
| 2025-02-26 | -2.53 USD | -3.65 USD | +30.7% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
SPCE valuation and analyst view
| Trailing P/E | -0.61 |
|---|---|
| Trailing EPS | -3.2603 USD |
| Price / book | 0.95 |
| Dividend yield | 0.00% |
| Market cap | 0.17B |
| Analyst consensus | Hold (5 buy / 7 hold / 5 sell) |
| Avg price target | 2.93 USD |
Related research pages
Frequently asked questions
When is Virgin Galactic Holdings (SPCE)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for SPCE. This page updates as the calendar is published.
Did SPCE beat earnings last quarter?
In its 2026-05-14 report, SPCE posted EPS of -0.81 USD versus a -0.79 USD estimate — a miss of 2.5%.
What is SPCE's earnings track record?
Over the last 5 reported quarters with consensus data, SPCE beat estimates 3 times (60%).
What is SPCE's current P/E ratio and EPS?
SPCE trades at a trailing P/E of -0.61 on trailing EPS of -3.2602979290908634 USD.
What do analysts rate SPCE?
Analyst consensus is "Hold" across 17 ratings (0 strong buy, 5 buy, 7 hold, 5 sell, 0 strong sell). Average 12-month price target: 2.93 USD.